
    
      Forty patients requiring cataract surgery will be randomized to treatment of post-operative
      inflammation with a single intraoperative dexamethasone injection plus a standard course of
      topical ophthalmic corticosteroid drops or the standard treatment alone. Dry eye testing will
      be administered at baseline, 1 week and 3 weeks following surgery.
    
  